Survival Analysis
10
2
2
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis
Survival Outcomes by Tumor-Node Stage and Recurrence Patterns in Colon Cancer After Radical Surgery
Primary Prevention Long-term Registry Study in OSA and Hypertension. Survival Analysis 2010-2022
Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes)
A Novel Nomogram to Predict the Postoperative Overall Survival in Gastrointestinal Cancer Patients
Predicting Disease Progression and/or Recurrence in Cancer
Medullary Colonic Carcinoma
Prognosis Factors in Patients With Primary Central Nervous System Lymphoma
Study of Cytochrome P450 Polymorphisms (CYP2D6, CYP3A4/5 and CYP2C19) in Breast Cancer Patients